The Icahn School of Medicine at Mount Sinai is recruiting for a full-time academic neuro-oncologist to serve as Division Chief of Neuro-Oncology in the Department of Neurology for the Mount Sinai Health System.
Applicants are sought at the Associate Professor or Professor rank, with an academic appointment at the Icahn School of Medicine at Mount Sinai that is commensurate with their experience and their resume. The selected candidate must have excellent clinical skills with an interest in outpatient and inpatient neuro-oncology care, a track record of clinical and/or translational research, as well as strong leadership skills. The selected candidate will be expected to provide equal effort in clinical care, research endeavors, and in leadership of the Division and co-director of a new brain cancer Center of Excellence. The selected candidate will also have the opportunity to lead the newly formed UCNS accredited neuro-oncology fellowship training program at Mount Sinai.
This leader will work with an outstanding team of neuro-oncologists, neuro-oncology nurse practitioners, neurosurgeons, radiation oncologists, and neuropathologists throughout the Mount Sinai Health System. The candidate will partner with the Department of Neurosurgery and serve as co-Director of a new Mount Sinai Brain Cancer Center of Excellence in the Tisch Cancer Institute to engage in advancing the clinical, research, and educational missions of this entity with specialized interests in primary brain tumors and metastatic tumors to the central nervous system.
The rapidly expanding neuro-oncology program at Mount Sinai has one of the largest brain tumor clinical volumes in NYC. The Division is active with clinical trials enrolling brain tumor patients in the Tisch Cancer Institute. New multidisciplinary brain cancer clinics exist within the health system. In 2019, the Icahn School of Medicine at Mount Sinai received UCNS accreditation for a neuro-oncology fellowship training program to educate the next generation of brain tumor specialists. The Brain Tumor Research Program at Mount Sinai currently has seven highly collaborative NIH-funded brain tumor research laboratories. Mount Sinai is a founding partner institution for the $300 million New York Proton Center, New York State’s first proton therapy facility, which opened in July 2019 in Upper Manhattan. We offer a competitive salary and benefits package.
ABPN certification in Neurology
Subspecialty fellowship training and board certification in neuro-oncology
Outstanding communication, bedside manner, and professionalism; excellent organizational skills
A strong work ethic and capability for effective collaboration in the multi-disciplinary care of patients with CNS tumors, including evaluation and enrollment in clinical trials
A track record of clinical and/or translational research and a vision for establishing a program of clinical and/or translational research in neuro-oncology at the Icahn School of Medicine at Mount Sinai
Leadership skills, experience and interest in directing a clinical brain tumor program and/or neuro-oncology fellowship training program are preferred
The Nash Family Department of Neuroscience at the Icahn School of Medicine at Mount Sinai received the third most biomedical research funding from the National Institutes of Health (NIH) of any medical school neuroscience department in the nation in 2019, according to data compiled and released by the Blue Ridge Institute for Medical Research (BRIMR). The Neuroscience Department received $37.3 million in awards during the NIH’s 2019 fiscal year, which included 41 awards for which department faculty members are Principal Investigators. Additionally, the Department of Neurology ranks No. 12 among neurology departments across the country in NIH funding, which reflects $21.8 million in awards received during the NIH’s 2019 fiscal year.
The Tisch Cancer Institute (TCI), a National Cancer Institute-designated center established in 2008, is an integral part of the Mount Sinai Health System, whose mission is to advance basic, clinical, and population health cancer research, in order to prevent disease or improve the lives of cancer patients. TCI has over 80 prominent scientists and physicians with an outstanding cancer clinical trials office, including built-in infrastructure for early phase clinical trials designed to maximize the development of cutting-edge therapies.
About the Mount Sinai Health System:
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes more than 7,200 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 400 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 30 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 15 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 15 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery in the 2020-2021 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in four out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology. Mount Sinai Beth Israel, Mount Sinai Morningside, and Mount Sinai West are ranked regionally.
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression.
Please specify Job Title of interest and send CV with Cover Letter to: